Neurophysiology and neuromodulators

Neurological Sciences

Volumn 28, Issue SUPPL. 2, 2007, Pages

  Aguggia, Marco ^a   D'Andrea, G ^b   Bussone, G ^c  

^a Neurology Department   (Italy)

^b Headache Center   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Brain hyperexcitability; Cortical spreading depression (CSD); Neuromodulators; Neurophysiology

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; ETIRACETAM; GABAPENTIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ARTICLE; BRAIN CORTEX; BRAIN DISEASE; CLINICAL TRIAL; COMORBIDITY; DRUG ACTIVITY; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; EPILEPSY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; MAGNETOENCEPHALOGRAPHY; MIGRAINE; MORBIDITY; NERVE CELL; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; OCCIPITAL CORTEX; PATHOPHYSIOLOGY; SENSORY STIMULATION; SPREADING CORTICAL DEPRESSION; SYMPTOM; SYNAPSE; TEMPORAL LOBE; VISUAL CORTEX;

ANIMALS; ANTICONVULSANTS; BRAIN; COMORBIDITY; EPILEPSY; HUMANS; MIGRAINE DISORDERS; NEURAL INHIBITION; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE;

EID: 34249297631     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0759-3     Document Type: Article

References (48)

1. Welch KMA (1997) Pathogenesis of migraine. Semin Neurol 17:335-341
2. Leao AA (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390
3. Sancez del Rio M, Reuter U (2004) Migraine aura: New information on underlying mechanisms. Curr Opin Neurol 17:289-293
4. Van Harreveld A (1978) Two mechanisms for spreading depression in the chicken retina. J Neurobiol 9:419-431
5. Welch KMA, D'Andrea G, Tepley N et al (1990) The concept of migraine as a state of central neuronal hyperexcitability. Headache 8:817-828
6. Aurora SK, Cao Y, Bowyer SM, Welch KMA (1999) The occipital cortex is hyperexcitable in migraine: Experimental evidence. Headache 39:469-476
7. Wray SH, Mijovic-Prelec D, Kosslyn SM (1995) Visual processing in migraineurs. Brain 118:25-35
8. Marcus DA, Soso MJ (1989) Migraine and stripe-induced visual discomfort. Arch Neurol 46:1129-1132
9. McColl SL,Wilkinson F (2000) Visual contrast gain control in migraine: measures of visual cortical excitability and inhibition. Cephalalgia 20:74-78
10. Mulleners WM, Chronicle EP, Palmer JE et al (2001) Suppression of perception in migraine: Evidence for reduced inhibition in the visual cortex. Neurology 56:178-183
11. Airy H (1870) On a distinct form of transient hemianopsia. Philos Trans R Soc Lond 160:247-264
12. Wilkins AAJ, Binnie CD, Darby CE (1980) Visually induced seizures. Prog Neurobiol 15:85-117
13. Shepherd AJ (2000) Visual contrast processing in migraine. Cephalalgia 20:865-880
14. Bowyer SM, Aurora SK, Moran JE et al (2001) Magnetoencephalographic field from patients with spontaneous and induced migraine aura. Ann Neurol 50:582-587
15. Cao Y, Welch KM, Aurora SK, Vikingstad EM (1999) Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 56:548-554
16. Aurora SK, Ahmad BK,Welch KMA et al (1998) Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology 50:1111-1114
17. Aguggia M, Zibetti M, Febbraro A, Mutani R (1999) Transcranial magnetic stimulation in migraine with aura: Further evidence of occipital cortex hyperexcitability. Cephalalgia 19:465
18. Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ (2002) Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 9:35-40
19. Young WB, Oshinsky ML, Shechter AL, Wasserman EM (2001) Consecutive transcranial magnetic stimulation induced phosphene thresholds in migraineurs and controls. Neurology 56:A142
20. Batelli L, Black KR, Wray SH (2002) Transcranial magnet-ic stimulation of visual area V5 in migraine. Neurology 58:1066-1069
21. Douglas RJ, Koch C, Mahowald M et al (1995) Recurrent excitation in neocortical circuits. Science 269:981-985
22. Hwa GGC, Avoli M, Oliver A, Villemure JG (1991) Bicuculline induced epileptogenesis in the human neocortex maintained in vitro. Exp Brain Res 83:329-339
23. Mitsias P, Al-Quasmi M, Norris L et al (1999) Serial changes in visual cortical excitability during the menstrual cycle of menstrual migraineurs. Cephalalgia 19:308
24. Welch KMA, Darnley D, Simkins RT (1984) The role of estrogen in migraine: A review and hypothesis. Cephalalgia 4:227-236
25. Fanciullacci C, Alessandri M, Fanciullacci M (1998) The relationship between stress and migraine. Funct Neurol 13:215-223
26. Peatfeld RC (1995) Relationship between food wine, and beer precipitated migrainous headaches. Headache 35:355-357
27. Welch KMA, Ramadan NM (1995) Mitochondria, magnesium and migraine. J Neurol Sci 134:9-14
28. Welch KMA, Levine SR, D'Andrea G et al (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39:538-554
29. Barbiroli B, Montagna P, Cortelli P et al (1992) Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42:1209-1214
30. Boska MD, Welch KM, Barker PB et al (2002) Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology 58:1227-1233
31. Ottman R, Lipton RB (1994) Comorbidity of migraine and epilepsy. Neurology 44:2105-2110
32. Low NC, Merikangas KR (2003) The comorbidity of migraine. CNS Spectr 8:433-434, 437-444
33. Andermann F, Lugaresi E (1987) Migraine and epilepsy. Butterworth, Boston, MA
34. Welch KMA, Lewis D (1997) Migraine and epilepsy. Neurol Clin 15:107-114
35. Welch KMA (2005) Brain hyperexcitability: The basis for antiepileptic drugs in migraine prevention. Headache 45[Suppl 1]:S25-S32
36. Haut SR, Bigal M, Lipton R (2006) Chronic disorders with episodic manifestation: Focus on epilepsy and migraine. Lancet Neurol 5:148-157
37. Freitag FG, Collins SD, Carlson HA et al (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58:1652-1659
38. Brandes JL, Saper JR, Diamond M et al (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
39. Mathew NT, Saper JR, Silberstein SD et al (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281-286
40. Mathew NT, Magnus-Miller L, Saper et al (1999) Migraine prophylaxis with gabapentine. Headache 39:367
41. Silberstein SD (2005) Topiramate in migraine prevention. Headache 45[Suppl 1]:S57-S65
42. Bussone G, Diener HC, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: A pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59:961-968
43. Diener HC, Tfelt-Hansen P, Dahlof C et al (2004) Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943-950
44. Silberstein SD, Neto W, Schmitt J, Jacobs D (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495
45. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE (2000) An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41:S3-S9
46. Storer RJ, Goadsby PJ (2004) Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia 24:1049-1056
47. Storer RJ, Akerman S, Goadsby PJ (2003) Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol 138:317-324
48. Akerman S, Goadsby PJ (2005) Topiramate inhibits cortical spreading depression in rat and cat: Impact in migraine aura. NeuroReport 16:1383-1387